Back

When should prolonged antiplatelet regimens be considered?

26 August 2023 (14:45 - 15:00)
Organised by: Logo
Congress Presentation Part of: Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration Acute Coronary Syndromes ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sergio Tavares Montenegro

Procape, Recife (Brazil)

3 More presentations in this session

Presentation thumbnail
Antiplatelet monotherapy in acute coronary syndromes: which patients and when
Professor P. Lemos (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Is prasugrel preferred over ticagrelor?
Professor A. Kastrati (Munich, DE)
Slides Video
Presentation thumbnail
Oral anticoagulant therapy with antiplatelet therapy: what is evidence-based practice?
Doctor R. Colleran (Dublin 7, IE)
Slides Video

Access the full session

Session thumbnail
Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 14:45 CET
You may be interested in
thumbnail
Congress Presentation
Shortening dual antiplatelet therapy duration: how, when and why?
thumbnail
Congress Presentation
Should 12 months of dual antiplatelet therapy still be the default recommendation after primary PCI?
thumbnail
Congress Session
Oral antiplatelet therapy after acute coronary syndromes: how to choose the best regimen and the optimum duration

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources